Provider: Thomson Reuters Stock Report
Provider: Wright Reports
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
UMN Pharma Inc Appoints Chairman of the Board and President
UMN Pharma Inc announced that it has appointed Tatsuyoshi Hirano as Chairman of the Board, President and Representative Director, to replace Masahiro Michishita, effective August 5, 2013.
Latest Developments for UMN Pharma Inc
Latest Key Developments in Biotechnology
- Threshold Pharmaceuticals Inc announces TH-302 Data at 55th annual meeting of the American Society of Hematology
- Seattle Genetics Inc presents data from novel antibody-drug Conjugate (ADC) SGN-CD19A
- ZIOPHARM Oncology Inc reports positive interim results in patients with Advanced Melanoma from Ongoing Phase 1/2 Study of Ad-RTS-IL-12
- BioSpecifics Technologies Corp announces FDA approval of XIAFLEX for treatment of peyronie's disease
- Share this
- Digg this